Vertex Pharmaceuticals Incorporated shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Rhenman & Partners Asset Management AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $6.9M | 35k | 197.73 |
| 2023-06-30 | $22M | 64k | 351.91 |
| 2023-03-31 | $26M | 84k | 312.16 |
| 2022-12-31 | $23M | 80k | 288.78 |
| 2022-09-30 | $30M | 96k | 312.00 |
| 2022-06-30 | $27M | 95k | 281.79 |
| 2022-03-31 | $23M | 90k | 260.97 |
| 2021-12-31 | $37M | 165k | 222.45 |
| 2021-09-30 | $30M | 165k | 181.39 |
| 2021-06-30 | $44M | 216k | 201.63 |
| 2021-03-31 | $36M | 168k | 214.89 |
| 2020-12-31 | $27M | 115k | 236.34 |
| 2020-09-30 | $30M | 110k | 272.12 |
| 2020-06-30 | $40M | 138k | 290.31 |
| 2020-03-31 | $27M | 115k | 237.95 |
| 2019-12-31 | $35M | 160k | 218.95 |
| 2019-09-30 | $32M | 186k | 169.42 |
| 2019-06-30 | $34M | 185k | 183.38 |
| 2019-03-31 | $27M | 144k | 183.95 |
| 2018-12-31 | $22M | 132k | 165.71 |
| 2018-09-30 | $28M | 143k | 192.74 |
| 2018-06-30 | $26M | 155k | 169.96 |
| 2018-03-31 | $24M | 150k | 162.98 |
| 2017-12-31 | $23M | 152k | 149.86 |
| 2017-09-30 | $27M | 180k | 152.04 |
| 2017-06-30 | $12M | 95k | 128.87 |
| 2017-03-31 | $10M | 95k | 109.35 |
| 2016-12-31 | $4.8M | 65k | 73.68 |
| 2016-09-30 | $7.0M | 80k | 87.21 |
| 2016-06-30 | $5.2M | 60k | 86.02 |
| 2016-03-31 | $6.2M | 78k | 79.49 |
| 2015-12-31 | $7.0M | 56k | 125.82 |
| 2015-09-30 | $11M | 105k | 104.14 |
| 2015-06-30 | $6.8M | 55k | 123.47 |
| 2015-03-31 | $6.8M | 58k | 117.97 |
| 2014-12-31 | $4.5M | 38k | 118.79 |
| 2014-09-30 | $4.8M | 43k | 112.30 |
| 2014-06-30 | $9.6M | 102k | 94.68 |
More positions owned by Rhenman & Partners Asset Management AB
Cigna Corp (CI)
View all positions for Rhenman & Partners Asset Management AB
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated